Upgrade to SI Premium - Free Trial

Amicus Therapeutics (FOLD) PT Lowered to $13 at BofA Securities

May 10, 2024 5:27 AM
BofA Securities analyst Tazeen Ahmad lowered the price target on Amicus Therapeutics (NASDAQ: FOLD) to $13.00 (from $14.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles